Artesunate Exhibits Synergy With Cisplatin and Cytotoxicity for Upper Tract and Bladder Urothelial Carcinoma Cells

doi:10.21873/anticanres.16263

Chia Nan University of Pharmacy & Science Institutional Repository > 環境永續暨休閒學院 > 運動管理系 > 期刊論文 > Item 310902800/34913

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34913

標題:	Artesunate Exhibits Synergy With Cisplatin and Cytotoxicity for Upper Tract and Bladder Urothelial Carcinoma Cells
作者:	Chen, San-Yuan Chao, Chun-Nun Huang, Hsin-Yi Zhao, Pei-Wen Fang, Chiung-Yao
貢獻者:	Ditmanson Med Fdn Chiayi Christian Hosp, Dept Chinese Med Chia Nan Univ Pharm & Sci, Dept Sports Management Ditmanson Med Fdn Chiayi Christian Hosp, Dept Paediat Asia Univ, Dept Biotechnol Ditmanson Med Fdn Chiayi Christian Hosp, Dept Med Res, 539 Chung Hsiao Rd, Chiayi 600, Taiwan
關鍵字:	Artesunate urothelial carcinoma ROS synergy cisplatin
日期:	2023
上傳時間:	2024-12-25 11:05:33 (UTC+8)
出版者:	INT INST ANTICANCER RESEARCH
摘要:	Background/Aim: Urothelial carcinoma (UC) may arise from the urothelium of the upper tract and the bladder. Cisplatin-based therapy remains the gold standard for UC treatment. The poor 5-year survival rate of UC patients creates an urgent need to develop new drugs for advanced UC therapy. Artesunate (ART), a traditional Chinese medicine for treating malaria, is a potential anticancer agent, but its antigrowth effects on upper tract and bladder UC have not been investigated. Materials and Methods: The antigrowth effect of ART in HT 1376 (bladder UC cells) and BFTC 909 [upper tract urothelial carcinoma (UTUC) cells] was determined by the CCK-8 assay. Flow cytometric analysis was used to evaluate the cell cycle distribution and apoptosis. The cell cycle, apoptosis, and autophagy-related protein expression were analyzed by western blotting. The efficacy of combination treatment with cisplatin was determined by the Calcusyn software. Results: ART induced HT 1376 and BFTC 909 cell death in a concentration- and time-dependent manner, inducing G2/M cell-cycle arrest. ART induced apoptosis and redox imbalance in HT 1376 and BFTC 909 cells. Application of the reactive oxygen species death in ART-treated UC cells. BFTC 909 cells show a better response after ART treatment. Conclusion: ART may be a candidate drug for treating UTUC and bladder UC while increasing the therapeutic effect of cisplatin.
關聯:	Anticancer Research, v.43, n.3, pp.1175-1184
顯示於類別:	[運動管理系] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	11	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....